{"name":"Collegium Pharmaceutical, Inc.","slug":"collegium-pharmaceutical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":780567000,"revenueGrowth":279.9,"grossMargin":0,"rdSpend":0,"netIncome":62870000,"cash":1656834000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oxycodone DETERx","genericName":"Oxycodone DETERx","slug":"oxycodone-deterx","indication":"Moderate to severe chronic pain requiring long-term opioid therapy","status":"phase_3"}]}],"pipeline":[{"name":"Oxycodone DETERx","genericName":"Oxycodone DETERx","slug":"oxycodone-deterx","phase":"phase_3","mechanism":"Oxycodone DETERx is an extended-release formulation of oxycodone, a mu-opioid receptor agonist, designed with abuse-deterrent technology to reduce the potential for misuse.","indications":["Moderate to severe chronic pain requiring long-term opioid therapy"],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxONXJaTzRpWTVReGIzaC1ZMmo1b0Y1eTZneVk2cFN0R25QNUpxSzFCdmduQmFLZXlsYS1YLVZmSmVVSW8xeVdSa1dHMXE2ZnlUaDZOZ2RoWnB6WFY4UXR4NGpxU0R4eUZkR29VRHV6YVl3R2h3d2o1eXUzVDlLR0lBUHJzWGdOU1Bqckx6S0M3T0piU011b2tENFJpYlotVzQyUTQ2emhNVUdnZw?oc=5","date":"2026-04-01","type":"pipeline","source":"IndexBox","summary":"Collegium Pharma Executive David Dieter Sells Shares in March 2026 - News and Statistics - IndexBox","headline":"Collegium Pharma Executive David Dieter Sells Shares in March 2026 - News and Statistics","sentiment":"neutral"},{"date":"2026-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPU1BQNjdiQUxiVGVhOWl4NTZNQkdRRXloTm5wSkRoVUJ0SHZyMG1KOUV5VWdTX2R3bk82T2k3RDVYdEZ6OXZudmlxa1NMcF9pc21hdXNwSnpVRHFVbFhrekU1NXBjNW8tU2FJUDRjd0hxV1pyS1VfZzcwWW1jb0VoNVUyX0Jxb0JVc28yM0VFOGFYcGRCbFkxcnlTalRROUEyWlQwMENmY2MwM0NFd2ZwUVBiUTFIV3ptTXBJcmFMbC1jSGZJejFaNXpjbXBOakMxbnc?oc=5","date":"2026-03-05","type":"trial","source":"GlobeNewswire","summary":"Collegium to Present New Real-World Data at PainConnect 2026 - GlobeNewswire","headline":"Collegium to Present New Real-World Data at PainConnect 2026","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQTW0yM2l4VGQ3SFJLbUVzMmwyMV9VZDV1OWlkNVQyTExwajU5WHFpb1A0eUlYQkRIQ0lGQXZFOEVieFh1REpoZlN4TkdCZUNmU0hpTC1mYmFrQmFfT2lVdG1kV1FTNzZmSjFPQmp2ZzMyTUR3T1JpcGFRTXQ1dE5tU1FnYlMyS1ZfWWhrcWJkM1ltMzgwODNUWjFsdHpUd0E?oc=5","date":"2026-02-24","type":"earnings","source":"Finviz","summary":"Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Finviz","headline":"Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPWWktUDl5c3B5aHRfSXlvZEJJR3lmRXpSbVduNlVZZlZoZjBoV2wwSGVrSF9xY2YtVnpRd3hXQzZ4eUcxWEVodDlBSml3MW1jcHVzV3ZsMTRDUGcyX2hIeERyMGFTNFhYLXJBZ2diekp5dEgyV2VHUmNSUlV4andTVzE3VEJOMVVJdi1mWFQzaFNrZ1BBSnpmZUZiSGFWbk5leTlKZQ?oc=5","date":"2026-01-21","type":"deal","source":"Seeking Alpha","summary":"Collegium Pharmaceutical: Buying The Projected Growth For 2026 - Seeking Alpha","headline":"Collegium Pharmaceutical: Buying The Projected Growth For 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxNbmhsQlV5d1gzMHdpdXhTZ0syaVRDZ0xVV2xlMXJvZEdUOW9Ra0t1U3lhRmdlX1MxMW84TTNvc0ljOVpCNl9VM2pCbmJTc3pGa1NUazZYejJJSVkyX3Z6dlpsS1JJcndKbGhWZU5RU2gxUjA0WXR1OTRmeGlrQkZpMHA2RU9Xd3puMXFydjJvOHJSQjZ5YmpSTkJrVXlfRk5zTXJZVWpjNkktZDhSTW1pcmljNnkxR2tHZTVvTm5YZWpOSFluS2Rsb21Id0h1ektuZDg3WnRtaGtjaWFiS0NoNGxnOHVLeTNRSUs4Y0NaOUgwWk5WVGtSbUkxbWl0SlFPaGdmX3VuZUFpNFVPcjl4UXVZdXNOMDZoWGhwVg?oc=5","date":"2025-10-29","type":"pipeline","source":"GlobeNewswire","summary":"Paris Hilton Collaborates with Collegium Pharmaceutical to - GlobeNewswire","headline":"Paris Hilton Collaborates with Collegium Pharmaceutical to","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-19","type":"pipeline","source":"simplywall.st","summary":"We Think Collegium Pharmaceutical (NASDAQ:COLL) Is Taking Some Risk With Its Debt - simplywall.st","headline":"We Think Collegium Pharmaceutical (NASDAQ:COLL) Is Taking Some Risk With Its Debt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPb2o4S3FueFNlMld2S1IyWmlsaThVWGs4M1lISEpMSjBzTEJTWFE0SW5LcElzU29fUk5zeXdyZHNKSW5fVjllbmphN3gxeFFqTFM2aVhxV1BnRjY4Sm1MbEw3N3ZzYWVpak1JUWNPYVJWajlmMVpCN1B4YkNXMXNuRTBjLV9VanFldWhNZQ?oc=5","date":"2025-10-08","type":"pipeline","source":"Yahoo Finance","summary":"Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - Yahoo Finance","headline":"Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOLTlEeFVSaHloN1prRXRTbTE2STl5WXhXSmlrRGVVeWtWQmV3RFFseDF4cS1nYVc0UnRWNFJhRnRDS1FlSk1hN3VKWjJwcVBrdTVueVROQUNWYlFBN0hCNFk4SGFPSHVFck9RSktVWXZzOXZtQnQ0MTE3Z0phYXMtOTdVT1BiYjhjX0tELVVDWHU0Y3VmUlg4T2YxVXNNWXRsQk9lR0dENnJIOS1zalNfRWJkQm9tZ2NuNWc0eGdNallPOXNucXFERDZn?oc=5","date":"2025-09-02","type":"pipeline","source":"BioXconomy","summary":"Leading the way in pharma finance: Collegium CFO Colleen Tupper shares her vision - BioXconomy","headline":"Leading the way in pharma finance: Collegium CFO Colleen Tupper shares her vision","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-10","type":"pipeline","source":"simplywall.st","summary":"Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st","headline":"Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQdm0teTBlUGpoamRqcjNWU3RLSDBOeEhzMF9OMjl3MW0zSEJ0d09CcXdjLWxORmo3Y2s2eEpHVzZQbkQzTS1vOWF1M1VabjI4WWpmbDJZazJaUExRZ3h5UVZsN1c1NGhzOXJZVzJCcHNQY09uWlBING1teWZmUHdiNUlheHctWnp0MEdvZnM4QW5FMkNYZmxoYzFvLW5jR2ZYdDBtWDFqSDFfTFo0Wm9PQlhJWUo?oc=5","date":"2025-06-30","type":"deal","source":"Seeking Alpha","summary":"Collegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD Drug - Seeking Alpha","headline":"Collegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQQWJla3FQQTlLVkJlejhiYlotQk8yV0Q0LXVraXRfSGlaMWVRdnFFQkZlMUMtZ1VHX0FFUDNoSmpGaXdlTVcwRzdYYmxlVTZnejNIX3VTU2tyX3hnaGdSY01WVlo2UkhMY0tXUHhEa29FdndKNkhsYzFaZE92LXBobXlNeXNxMEx3SzR1eVhQS3BNQW9jTEN1MHd4MXVqdGM?oc=5","date":"2025-05-03","type":"pipeline","source":"GuruFocus","summary":"BlackRock, Inc. Reduces Stake in Collegium Pharmaceutical Inc. - GuruFocus","headline":"BlackRock, Inc. Reduces Stake in Collegium Pharmaceutical Inc.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":780567000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":780567000,"period":"2025-12-31"},{"value":205449000,"period":"2025-12-31"},{"value":209361000,"period":"2025-09-30"},{"value":188000000,"period":"2025-06-30"},{"value":177757000,"period":"2025-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":0,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":62870000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":1656834000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}